Results 71 to 80 of about 7,096 (184)

Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series

Reumatismo, 2017
Demyelinating syndrome (DS) is a rare manifestation of systemic lupus erythematosus (SLE) (1%) with high clinical heterogeneity and potentially severe prognosis. It can represent a diagnostic and therapeutic challenge for clinicians.
E. Chessa, M. Piga, A. Floris, A. Mathieu, A. Cauli   +4 more
doaj   +1 more source

Pediatric Therapeutic Plasma Exchange: Characterization of Practice, Epidemiology, and Safety Profile at a Children's Hospital in the United States

Journal of Clinical Apheresis, Volume 41, Issue 3, June 2026.
ABSTRACT There is a need to better understand the indications and safety profiles for therapeutic plasma exchange (TPE) in children. We aimed to assess pediatric TPE practice at a large academic center by retrospective chart review from 2011 to 2022. Patient demographics and clinical information including American Society for Apheresis (ASFA) category ...
Benjamin C. Lee, Brian D. Adkins, Ayda Javanbakht, Hung S. Luu, Daniel K. Noland   +4 more
wiley   +1 more source

Neuro-ophthalmic manifestation of neuromyelitis optica spectrum disorders

Chinese Journal of Contemporary Neurology and Neurosurgery, 2014
Neuromyelitis optica spectrum disorders (NMOSDs) include classic neuromyelitis optica (NMO), opticospinal multiple sclerosis (OSMS), limited form of NMO and isolated optic neuritis or myelitis accompanied by either systemic autoimmune diseases or ...
Xiao-jun ZHANG, Xian-hao XU
doaj  

Pain in patients with neuromyelitis optica spectrum disorders

Неврология, нейропсихиатрия, психосоматика
Neuromyelitis optica spectrum disorders (NMOSD) are a group of chronic autoimmune diseases of the central nervous system with a relapsing course. Unfortunately, the symptoms of exacerbation cannot always be completely stopped, and in addition to motor ...
E. S. Novikova, A. S. Kotov, S. V. Kotov
doaj   +1 more source

The Association Between MOG‐IgG Positivity and mRNA SARS‐CoV‐2 Vaccination in Denmark: A Self‐Controlled Case Series Study

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 6, June 2026.
ABSTRACT Purpose Spontaneous reporting of a possible link between myelin oligodendrocyte glycoprotein (MOG) antibody‐associated disease (MOGAD) and mRNA SARS‐CoV‐2 vaccination warrants further examination. Hence, the objective of this study was to investigate the association between MOG‐IgG positivity as a proxy for MOGAD and mRNA SARS‐CoV‐2 ...
Tine Iskov Kopp, Anne Katrine Andreasen, Viktoria Papp, Mette Hjorslev Knudgaard, Heidi Jeannet Graff, Michelle S. Clement, Nicklas Hasselblad Lundstrøm, Stine Ulsø, Mona El‐Sayed Hervig, Charlotte Wessel Skovlund   +9 more
wiley   +1 more source

Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders

Multiple Sclerosis Journal - Experimental, Translational and Clinical, 2018
Background Pain is a frequent symptom in aquaporin-4-immunoglobulin-G-positive neuromyelitis optica spectrum disorders (AQP4-IgG-pos. NMOSD). Data on pain in myelin-oligodendrocyte-glycoprotein-immunoglobulin-G autoimmunity with a clinical NMOSD ...
Susanna Asseyer, Felix Schmidt, Claudia Chien, Michael Scheel, Klemens Ruprecht, Judith Bellmann-Strobl, Alexander U Brandt, Friedemann Paul   +7 more
doaj   +1 more source

Reply to Letter: “Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring” by Saccà and Pelto Regarding “Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab”

Annals of Clinical and Translational Neurology, Volume 13, Issue 6, Page 1303-1304, June 2026.
Lea Gerischer, Jutta Schroeder‐Braunstein, Guido Wabnitz, Andreas Meisel   +3 more
wiley   +1 more source

Differences in Income Growth Between People With Multiple Sclerosis and Controls: A Norwegian Cohort Study

European Journal of Neurology, Volume 33, Issue 6, June 2026.
Income growth was significantly lower for people with MS compared to controls, and men with MS lost income at a younger age than women with MS (49 vs. 55 years). Men also lost income earlier in the disease course than women (2 vs. 5 years post‐diagnosis).
Anne Høgset, Cecilia Smith Simonsen, Heidi Øyen Flemmen, Cathrine Brunborg, Line Broch, Pål Berg‐Hansen, Elisabeth Gulowsen Celius   +6 more
wiley   +1 more source

An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica

Therapeutic Advances in Neurological Disorders, 2016
Neuromyelitis optica spectrum disorders (NMOSDs) is a new concept which includes classical neuromyelitis optica (NMO) and partial forms of NMO such as recurrent optic neuritis with positive aquaporin-4 antibodies (AQP4) or brainstem symptoms (intractable
Nicolas Collongues, Jérôme de Seze
doaj   +1 more source

Update on neuromyelitis optica: natural history and management

Eye and Brain, 2012
Panitha Jindahra1,2, Gordon T Plant1,21The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK; 2St Thomas' Hospital, Westminster Bridge Road, London, UKAbstract: Neuromyelitis optica or Devic disease is an inflammatory ...
Jindahra P, Plant GT
doaj